Answers are grounded in this paper and cite their sources.
Industry 6.0 changes healthcare delivery in LATAM, exploring responsibilities and future developments.
Of all the sectors where Industry 6.0 in healthcare is landing, none has a dilemma as sharp as the medical one: agents can measurably improve diagnosis and coverage, but the cost of an error is human, not accounting. I have been working with public and private health systems in five countries in the region, and the conclusion is always the same: the question is no longer whether clinical agents will enter hospitals and primary care centers, but under what accountability framework. In this article I walk through what is being agentified today, what is in serious planning for 2027-2030, and what three conditions a health system must meet not to be left out of the agentic healthcare economy.
No takes yet. Share an insight, caveat, or question.
Chris Meniw (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: